Delivery Order SPE2DR25D3301-SPE2DR26F22EG

The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for Ocrevus 300 mg/10 ml vial 10 ml, with a ceiling value of $76,913.10. Place of performance is Conshohocken, PA. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (SPE2DX), a global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026, which enables supply of a comprehensive range of pharmaceutical products and medical supplies...

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 9, 2026, with a ceiling value of $25,637.70 for OCREVUS 300 mg/10 mL vial (10 mL).</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of March 3, 2026. No set-aside was used.</p>

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Ocrevus 300 mg/10 mL vials with a ceiling value of $48,077.16 and a firm fixed price contract type. The delivery order is scheduled for completion by November 25, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This non-set-aside award was competitively awarded and represents a child delivery order under a larger contract...

The Defense Logistics Agency awarded a $72,115.74 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Ocrevus 300 mg/10 ml vials. This firm fixed-price contract, with an ultimate completion date of October 10, 2025, represents a direct delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively procured with no set-aside designation and will be performed at AmerisourceBergen's...

The Defense Logistics Agency awarded a $51,275.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Ocrevus 300 mg/10 mL vials. This competitive award with no set-aside designation is scheduled for completion by February 19, 2026, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a task order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical,...

The Defense Logistics Agency awarded a $120,192.80 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Ocrevus 300 mg/10 mL vials. This is a firm fixed-price contract with an ultimate completion date of August 14, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal pharmaceutical...

The Defense Logistics Agency awarded a $64,447.63 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Ocrevus 300 mg/10 mL vials. This is a firm fixed price contract with a completion date of December 22, 2025, and represents a non-competitive delivery order issued under an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Ocrevus 300 mg/10 ml vials with a ceiling value of $253,329.60 and an ultimate completion date of December 2, 2025. This firm fixed-price delivery order is unclassified as a set-aside contract and represents a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken,...

The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Ocrevus 300 mg/10 ml vials. This competitively awarded, firm fixed-price delivery order has a ceiling value of $50,665.92 and an ultimate completion date of December 29, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...

The Defense Logistics Agency awarded a delivery order valued at $51,275.40 to AmerisourceBergen Drug Corp for the supply of Ocrevus 300 mg/10 mL vials on January 22, 2026, with an ultimate completion date of February 12, 2026. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded transaction within the federal pharmaceutical procurement process. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where...